Diversified Consumer Services
Company Overview of University of Hong Kong
University of Hong Kong is an educational institution.
The University Of Hk
Sai Ying Poon,
Key Executives for University of Hong Kong
Professor and Chair of Accounting
Compensation as of Fiscal Year 2014.
University of Hong Kong Key Developments
University of Hong Kong Has Appoints Tzi Sum Andy Hor as Vice-President/Pro-Vice-Chancellor (Research) and W John Kao as Vice-President/Pro-Vice-Chancellor (Global)
Mar 10 15
The Council of the University of Hong Kong has appointed Tzi Sum Andy Hor as the Vice-President/Pro-Vice-Chancellor (Research) and W John Kao as the Vice-President/Pro-Vice-Chancellor (Global), each for a term of five years. Tzi Sum Andy Hor is currently on secondment from the National University of Singapore (NUS) as the Executive Director of the Institute of Materials Research & Engineering (IMRE) of the Agency for Science, Technology & Research of Singapore. W John Kao is currently an executive director of the Institute for Clinical and Translational Research.
Hong Kong University Appoints Andy Hor Tzi Sum as Vice-President and Pro-Vice-Chancellor (Research), Effective September 1, 2015
Mar 10 15
Professor Andy Hor Tzi Sum, Executive Director (ED) of IMRE, has been appointed as Vice-President and Pro-Vice-Chancellor (Research) at Hong Kong University. Prof Hor is expected to take up his new appointment on 1 September 2015. Prof Hor has been at the helm of A*STAR’s IMRE since June 2010. He is on secondment from the National University of Singapore (NUS) where he is Professor of Chemistry. Prof Hor is also Concurrent Professor at Fudan University of China.
Advanced Biological Laboratories, The University of Hong Kong and The Hong Kong Polytechnic University Decide to Join Forces to Develop a Deep-Sequencing Tuberculosis Solution
Oct 14 14
Advanced Biological Laboratories (ABL), S.A, The University of Hong Kong and The Hong Kong Polytechnic University announced the launching their collaborative tuberculosis (TB) project to develop a deep-sequencing assay and its tailored bio-informatics pipeline. This aims to enable early and improved diagnosis of TB when there is an increasingly drug resistant strains of TB emerging world-wide with multi-drug resistance. Under the terms of agreement, The University of Hong Kong will provide data and knowledge, while The Hong Kong Polytechnic University will insure the TB assay development required to perform NGS sequencing. This assay will be used in combination with the DeepChek(R) Tuberculosis software application. These will be validated with retrospective and prospective clinical specimens. ABL will optimize its DeepChek(R) platform technology for this TB assay with whole genome sequencing data analysis and other TB specificities. Other terms of the agreement are not disclosed.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries